Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001205580 | SCV001376842 | uncertain significance | Cranioectodermal dysplasia 1 | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 918 of the IFT122 protein (p.Pro918Thr). This variant is present in population databases (rs144831946, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with IFT122-related conditions. ClinVar contains an entry for this variant (Variation ID: 936724). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001205580 | SCV002804002 | uncertain significance | Cranioectodermal dysplasia 1 | 2021-12-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002561191 | SCV003713574 | uncertain significance | Inborn genetic diseases | 2021-10-12 | criteria provided, single submitter | clinical testing | The c.2752C>A (p.P918T) alteration is located in exon 22 (coding exon 22) of the IFT122 gene. This alteration results from a C to A substitution at nucleotide position 2752, causing the proline (P) at amino acid position 918 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |